DENTSPLY Sirona Inc (XRAY) gains 1.89% for July 21

Equities Staff  |

DENTSPLY Sirona Inc (NASDAQ: XRAY) shares gained 1.89%, or $1.18 per share, to close Wednesday at $63.76. After opening the day at $62.93, shares of DENTSPLY Sirona fluctuated between $63.97 and $62.93. 1,238,968 shares traded hands an increase from their 30 day average of 1,182,119. Wednesday's activity brought DENTSPLY Sirona’s market cap to $13,919,963,395.

DENTSPLY Sirona is headquartered in York, Pennsylvania..

About DENTSPLY Sirona Inc

Dentsply Sirona is the world's largest manufacturer of professional dental products and technologies, with a 134-year history of innovation and service to the dental industry and patients worldwide. Dentsply Sirona develops, manufactures, and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands. As The Dental Solutions Company, Dentsply Sirona's products provide innovative, high-quality and effective solutions to advance patient care and deliver better, safer and faster dentistry.

Visit DENTSPLY Sirona Inc’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on DENTSPLY Sirona Inc and to follow the company’s latest updates, you can visit the company’s profile page here: DENTSPLY Sirona Inc’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content